Mitochondrial dysfunction aligns with risk for diabetic kidney disease in youth with type 1 diabetes

No Thumbnail Available
File version
Author(s)
Sullivan, Mitchell
Mccarthy, Domenica
Flemming, Nicole
Chandrashekar, Preeti
Hodson, Mark
Fotheringham, Amelia
Whiddett, Rani
De Silva, Neisha
Nisbet, Jinelle
Morton, Adam
Teasdale, Stephanie
Isbel, Nicole
Jones, Timothy
Couper, Jennier
Thorburn, David
et al.
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
2022
Size
File type(s)
Location

Sydney, Australia

License
Abstract

Aims: Determine if mitochondrial dysfunction in adolescents with T1D contributes to an increased risk of developing DKD.

Background: Diabetic kidney disease (DKD), affecting ~1/3 of people with type 1 diabetes (T1D), is the leading cause of chronic kidney disease and kidney failure. DKD begins as early as adolescence, with the highest tertile of urinary albumin-to-creatinine ratio (uACR) predicting those at greatest future risk. This study tested the hypothesis that.

Methods: This cross-sectional cohort study recruited 100 young adults with T1D. Mean uACR was determined and the cohort was then divided into low (uACR ≤0.66 mg/mmol; n = 33), middle (uACR 0.67–1.16; n = 33) and high-risk groups for DKD (uACR ≥1.17; n = 34). Mitochondrial stress tests were performed in PBMCs using Seahorse. Flow cytometry quantified mitochondrial intensity in various blood derived T cells. Human kidney cells (PTECs) were exposed to participant serum and mitochondrial stress tests and fatty acid oxidation assays were performed using Seahorse. Mitochondrial intensity and collagen IV levels were measured using confocal microscopy and SGLT2 levels by flow cytometry.

Results: PBMCs from the high-risk group had greater mitochondrial intensities in CD3+ and CD4+/FOXP3+ T cells and lower basal and ATP-linked respiration (p < 0.05). PTECS treated with high-risk serum had higher collagen IV and SGLT2 expression (p < 0.05). PTECs also showed less ability for non-fatty acid dependent respiration compared to the cells treated with serum from low-risk patients (p < 0.0001).

Conclusion: Both the PBMCs of participants in the high-risk group and kidney cells treated with their serum demonstrated altered mitochondrial function, with serum-treated cells also having increased levels of collagen IV and SGLT2. These results may help better inform clinicians and patients regarding early risk factors for the development of DKD.

Journal Title

Nephrology

Conference Title

57th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology (ANZSN)

Book Title
Edition
Volume

27

Issue

S1

Thesis Type
Degree Program
School
DOI
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement
Item Access Status
Note
Access the data
Related item(s)
Subject

Metabolic medicine

Medical biochemistry and metabolomics

Nephrology and urology

Clinical sciences

Life Sciences & Biomedicine

Science & Technology

Urology & Nephrology

Persistent link to this record
Citation

Sullivan, M; Mccarthy, D; Flemming, N; Chandrashekar, P; Hodson, M; Fotheringham, A; Whiddett, R; De Silva, N; Nisbet, J; Morton, A; Teasdale, S; Isbel, N; Jones, T; Couper, J; Thorburn, D; Johnson, D; Cotterill, A; Barrett, H; O'Moore-Sullivan, T; Donaghue, K; Forbes, J, Mitochondrial dysfunction aligns with risk for diabetic kidney disease in youth with type 1 diabetes, Nephrology, 2022, 27 (S1), pp. 32-33